Table 2.

Mean hit rates and false alarms for the conditions of interest (SD in parentheses)

RememberKnow
RewardNeutralRewardNeutral
HitsFalse alarmsHitsFalse alarmsHitsFalse alarmsHitsFalse alarms
All (n = 29)
    Placebo
        Early0.32 (0.23)0.12 (0.15)0.27 (0.22)0.07 (0.10)0.19 (0.17)0.13 (0.11)0.14 (0.15)0.08 (0.13)
        Delay0.22 (0.17)0.06 (0.08)0.24 (0.17)0.08 (0.12)0.16 (0.14)0.12 (0.13)0.15 (0.13)0.08 (0.09)
    l-DOPA
        Early0.36 (0.22)0.10 (0.13)0.31 (0.19)0.11 (0.11)0.18 (0.14)0.14 (0.15)0.20 (0.16)0.11 (0.12)
        Delay0.23 (0.23)0.06 (0.09)0.23 (0.16)0.07 (0.11)0.16 (0.13)0.14 (0.13)0.17 (0.13)0.11 (0.11)
Low-dose group (n = 10)
    Placebo
        Early0.22 (0.16)0.10 (0.16)0.25 (0.24)0.07 (0.11)0.28 (0.18)0.17 (0.15)0.19 (0.21)0.15 (0.18)
        Delay0.15 (0.13)0.04 (0.06)0.19 (0.12)0.04 (0.05)0.22 (0.19)0.13 (0.16)0.20 (0.17)0.11 (0.09)
    l-DOPA
        Early0.29 (0.24)0.09 (0.09)0.18 (0.16)0.15 (0.14)0.20 (0.12)0.19 (0.18)0.25 (0.16)0.15 (0.13)
        Delay0.18 (0.20)0.03 (0.03)0.17 (0.15)0.08 (0.13)0.19 (0.15)0.13 (0.09)0.17 (0.11)0.10 (0.08)
Middle-dose group (n = 9)
    Placebo
        Early0.41 (0.27)0.17 (0.15)0.30 (0.22)0.09 (0.12)0.13 (0.13)0.13 (0.12)0.12 (0.13)0.02 (0.03)
        Delay0.24 (0.14)0.09 (0.09)0.24 (0.16)0.11 (0.13)0.12 (0.10)0.11 (0.12)0.06 (0.06)0.07 (0.11)
    l-DOPA
        Early0.45 (0.18)0.16 (0.15)0.43 (0.15)0.11 (0.11)0.16 (0.11)0.14 (0.15)0.18 (0.19)0.12 (0.15)
        Delay0.35 (0.30)0.10 (0.13)0.37 (0.18)0.08 (0.13)0.13 (0.10)0.11 (0.10)0.17 (0.16)0.13 (0.09)
High-dose group (n = 10)
    Placebo
        Early0.35 (0.22)0.09 (0.13)0.27 (0.21)0.05 (0.08)0.16 (0.16)0.09 (0.34)0.13 (0.08)0.07 (0.09)
        Delay0.27 (0.22)0.05 (0.07)0.29 (0.22)0.09 (0.15)0.13 (0.09)0.11 (0.09)0.16 (0.12)0.05 (0.06)
    l-DOPA
        Early0.34 (0.23)0.06 (0.12)0.31 (0.17)0.06 (0.07)0.18 (0.18)0.10 (0.12)0.17 (0.13)0.07 (0.05)
        Delay0.17 (0.16)0.07 (0.08)0.18 (0.08)0.05 (0.04)0.16 (0.15)0.19 (0.17)0.15 (0.11)0.11 (0.15)